Medical News. A recent study showed that antihypertensive medications for cholesterol levels in the body,
"statins" may reduce the risk of esophageal cancer, especially for patients with Barrett Bmre.
There are two types of esophageal cancer; squamous cell carcinoma or glandular cancer. And Barrett's esophagus is one of the complications of gastroesophageal reflux disease, which increases the likelihood of glandular cancer, the most common type of cancer of the esophagus.
Barrett's esophagus is considered a pre-cancer, where the lining of the esophagus, a channel carrying food from the throat to the stomach have been damaged by stomach acids.
Although the non-proliferation of esophageal cancer glandular However, the number of injury on the rise, where are diagnosed 16,000 cases of esophageal cancer each year in the United States, 60% of these cases, the type of glandular cancer. And only one of the 5 patients with this type of cancer survive for five years after diagnosis, and this Van prevent injury of the key things for this kind of cancer.
The researchers compared data from 13 previous studies, which included more than 1.1 million patients, including 9.285 diagnosed with esophageal cancer. The analysis found that statins reduced the risk of cancer by almost a third, and the longer the time to use the patient's statin was raised better protection.
The researchers given to the effect of aspirin in reducing the risk of developing esophageal cancer. When discussed in infected Bmre Barrett found that patients who took statins and aspirin together was esophageal cancer risk less by 72%.
The researchers said that these results encourage large random carry out experiments to assess statin drugs on patients who have a high probability of cancer of the esophagus.
The factors that increase the risk of esophageal cancer in addition to injury Barrett Bmre, male sex, and obesity and smoking.
ليست هناك تعليقات:
إرسال تعليق